Drug Discovery · San Diego, CA · Founded 2024 · Privately Held (backing)
Operator of a biotechnology research designed to create novel, easy-to-administer therapies for autoimmune diseases. Candid Therapeutics is based in San Diego, CA and was founded in 2024. It was valued at $657 million at its Series B in Aug 2024, the last priced event on record. It has raised $445 million across 1 recorded round; the latest was a $370 million Series B in Aug 2024.
PMV mark · valuation
$657.0M
Oct 2026
Priced at
its Series B
Aug 2024
Total raised
$445.0M
Last round
Early Stage VC (Series B)
Aug 2024
Team — not yet on record
No current team members for Candid Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Candid Therapeutics with a free account
·The complete investor list: 21 names
·Watch Candid Therapeutics: the Monday email on marks, rounds and moves
